Research Partnership
Deep Dive/ Featured content right column/ Market Access/ Views & Analysis/ Views and analysis
How to improve payer engagement with tailored value communication
mike.hammerton@pharmaphorum.com
Cecilie Alstad, Deep Dive, Deep Dive: Market Access, market access, Research Partnership
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
3 practical steps for improving patient support
mike.hammerton@pharmaphorum.com
Deep Dive, Emilie Braund, Harrison Gaiger, patients, Patients and Partnerships 2020, Research Partnership
0 Comment
Deep Dive/ Digital/ Views & Analysis/ Views and analysis
3 innovations booming during COVID-19
mike.hammerton@pharmaphorum.com
COVID-19, Deep Dive, digital health, Digital Health Innovation 2020, Research Partnership, Vicki Newlove
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Breaking policy and perceptual barriers: Biosimilars
mike.hammerton@pharmaphorum.com
biosimilars, Deep Dive: Market Access, Research Partnership, Rheumatoid arthritis
0 Comment
Deep Dive/ Oncology/ Views & Analysis
The promise and pitfalls of molecular testing in oncology
mike.hammerton@pharmaphorum.com
cancer, Deep Dive: Oncology and ASCO 2019, Dr Chris Gaj, erlotinib, Genentech, OSI, Research Partnership, Roche
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
China in the fast lane
mike.hammerton@pharmaphorum.com
Boon Yap, Brett Gardiner, China, Deep Dive: Access and Commercialisation, market access, Research Partnership
0 Comment
Deep Dive/ Digital/ Market Access
Deep Dive: Access and Commercialisation
mike.hammerton@pharmaphorum.com
bluebird bio, Idea Pharma, Impetus Digital, Janssen, LEO Pharma, market access, NHS England, Research Partnership, Sandoz, US healthcare reform
0 Comment
Debates & Insights/ R&D/ Webinars/ Webinars in home page/ Webinars On demand
Navigating new frontiers: Ways to find space in the future RA market
louise.bellamy@pharmaphorum.com
JAK inhibitor, RA, Research Partnership, Rheumatoid arthritis
0 Comment